Aiden Aceves

Aiden Aceves, Ph.D., is an accomplished professional in the biotechnology sector, currently serving as a Board Observer at 858 Therapeutics and several other companies, including Profluent Bio, Capacity Bio, DEM Biopharma, Inc., Switch Therapeutics, and ImmuneBridge since 2022. Aiden holds the position of Board Director at Basking Biosciences Inc. and Cirsium Biosciences, Inc., and at Stealth RNA Biotech Company and Superluminal Medicines Inc. since 2023. Aiden earned a Doctor of Philosophy in Bioengineering at Caltech from 2017 to 2021 and holds a Bachelor's Degree in Chemistry from the University of California, Riverside.